Tirzepatide dosing guide: dual GLP-1/GIP mechanism, SURMOUNT trial data, 2.5 to 15mg titration, contraindications, drug interactions, and free calculator.
✓ FDA-Approved: Tirzepatide is FDA-approved as Zepbound (for weight management) and Mounjaro (for type 2 diabetes). Both brands contain the same molecule and follow the same dosing protocol.
Dual GLP-1/GIP mechanism: enhanced appetite suppression and metabolic benefits
Tirzepatide (Mounjaro/Zepbound) is a dual GLP-1/GIP receptor agonist. In SURMOUNT-1, participants on the highest dose (15mg) lost an average of 20.9% of body weight over 72 weeks, numbers that previously required bariatric surgery.
The tirzepatide dosing protocol involves a gradual titration over 20+ weeks. Unlike semaglutide which has a single maintenance dose (2.4mg), tirzepatide offers three maintenance dose options (5mg, 10mg, 15mg), allowing for individualized treatment based on response and tolerability.
📋 Brand Information: Zepbound is for chronic weight management. Mounjaro is for type 2 diabetes. Same medication, same doses, different indications. Compounded tirzepatide follows the same protocol.
Important: Unlike semaglutide, tirzepatide has multiple maintenance doses. You can stay at 5mg, 10mg, or 15mg long-term. There’s no requirement to reach the maximum dose. Choose based on your individual response and tolerability.
the best ways to reduce high hematocrit from boldenone use
how long should you stay off gear after a 16 week cycle
why your bloodwork is more important than your mirror progress
Latest Post: Nandrolone Phenylpropionate vs Decanoate (DECA) Benefits Our newest member: Josh Sutton Recent Posts Unread Posts
